Page last updated: 2024-08-24

rhodamine 123 and nutlin-3a

rhodamine 123 has been researched along with nutlin-3a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cinatl, J; Doerr, HW; Fehse, B; Kammerer, B; Klassert, D; Michaelis, M; Rothweiler, F; von Deimling, A; Weber, K	1

Other Studies

1 other study(ies) available for rhodamine 123 and nutlin-3a

Article	Year
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer research, 2009, Jan-15, Volume: 69, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Mice; Mutation; Neuroblastoma; Piperazines; Proto-Oncogene Proteins c-mdm2; Rhabdomyosarcoma, Alveolar; Rhodamine 123; Stereoisomerism; Tumor Suppressor Protein p53; Vincristine	2009

Article

Year

Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.

Cancer research, 2009, Jan-15, Volume: 69, Issue:2

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Mice; Mutation; Neuroblastoma; Piperazines; Proto-Oncogene Proteins c-mdm2; Rhabdomyosarcoma, Alveolar; Rhodamine 123; Stereoisomerism; Tumor Suppressor Protein p53; Vincristine

2009